Lee Hyo-Suk
Liver Center, Myongji Hospital, Goyang-si, Gyeonggi-do, Korea.
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):62-64. doi: 10.5005/jp-journals-10018-1170. Epub 2016 Jul 9.
Korea has been one of the endemic areas of hepatitis B virus (HBV; exclusively genotype C) infection since ancient times. The epidemiology of HBV in Korea is easily expected to have changed over the last two decades owing to the high coverage rate of universal HBV vaccination. The main mode of hepatitis C virus (HCV) infection may have been effectively blocked since 1992 when compulsory blood screening for anti-HCV was implemented, and consequently, the prevalence of anti-HCV is also expected to have markedly decreased during the last two decades. This review will briefly describe what really happened during the last couple of decades in the epidemiology of HBV and HCV and in the incidence and mortality rates of liver cirrhosis (hepatic failure) and hepatocellular carcinoma in Korea.
Lee H-S. Viral Hepatitis in Korea: Past, Present, and Future. Euroasian J Hepato-Gastroenterol 2016;6(1):62-64.
自古以来，韩国就是乙肝病毒（HBV；仅C基因型）感染的流行地区之一。由于乙肝疫苗普遍接种的高覆盖率，预计韩国乙肝病毒的流行病学在过去二十年中发生了变化。自1992年实施抗丙肝病毒强制血液筛查以来，丙型肝炎病毒（HCV）感染的主要传播途径可能已得到有效阻断，因此，预计在过去二十年中抗丙肝病毒的流行率也显著下降。本综述将简要描述过去几十年韩国乙肝病毒和丙肝病毒的流行病学以及肝硬化（肝衰竭）和肝细胞癌的发病率和死亡率实际发生了什么。
Lee H-S. Viral Hepatitis in Korea: Past, Present, and Future. Euroasian J Hepato-Gastroenterol 2016;6(1):62-64.
